DOKLADY PHYSICAL CHEMISTRY is a prominent peer-reviewed journal published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focusing on advancements and research in the field of Physical and Theoretical Chemistry. With the ISSN 0012-5016 and E-ISSN 1608-3121, this journal serves as a vital platform for researchers and practitioners to disseminate their findings and insights from 1996 to the present. Despite its current Q4 ranking in the 2023 category of Physical and Theoretical Chemistry, the journal has shown significant potential for visibility and engagement within the academic community, ranking #149 out of 189 in its respective field according to Scopus metrics, highlighting its dedicated readership. While the journal is not open access, it remains an essential resource for those seeking in-depth research articles, reviews, and commentary within this dynamic discipline. As the field continues to evolve, DOKLADY PHYSICAL CHEMISTRY plays a crucial role in fostering scientific dialogue and collaboration among researchers, professionals, and students worldwide.

Molbank is an open-access journal published by MDPI, dedicated to the fields of Biochemistry, Organic Chemistry, and Physical and Theoretical Chemistry. Established in 2002, this journal has served as a vital platform for the dissemination of research findings, where researchers and professionals share original articles focusing on molecular chemistry, synthesis, and related studies. With a commitment to open access, Molbank enables global access to scientific knowledge, fostering collaboration and innovation among scientists. While currently categorized in the fourth quartile for its field rankings, it provides a unique opportunity for emerging scholars to contribute to and engage with the scientific community. The journal is based in Switzerland, operating from its office at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, and continues to attract submissions until 2024. Researchers, students, and professionals looking to expand their knowledge and participate in the dialogue of current molecular chemistry can benefit significantly from engaging with the content published in Molbank.

Heteroatom Chemistry is a prominent open-access journal dedicated to advancing the field of heteroatom chemistry, with a particular focus on the chemistry of elements other than carbon in organic compounds. Published by Wiley-Hindawi, this journal provides researchers, professionals, and students with a platform to disseminate and access novel research findings related to the synthesis, properties, and applications of heteroatom-containing compounds. Since its inception in 1990 and gaining open access status in 2019, the journal has fostered academic collaboration and innovation throughout its converged years, although it currently holds a category quartile ranking of Q4 in Chemistry (miscellaneous) and ranks #319 out of 408 in general chemistry within Scopus. With its commitment to high-quality research and broad accessibility, Heteroatom Chemistry is poised to be an essential resource for anyone looking to explore the rich and varied applications of heteroatom chemistry in diverse scientific fields.

Synthetic Communications, published by Taylor & Francis Inc, stands as a pivotal resource in the field of organic chemistry since its inception in 1971. With an ISSN of 0039-7911 and an E-ISSN of 1532-2432, this journal has established a commendable reputation, holding a Q3 ranking in organic chemistry by 2023, reflecting its contributions to the discipline and positioning it within the 50th percentile according to Scopus rankings. Targeted towards researchers, professionals, and students alike, Synthetic Communications aims to disseminate significant advancements in synthetic methodologies and reactions, facilitating the exchange of innovative ideas and enhancing collaborative efforts in the scientific community. Although not an open-access journal, it offers a wealth of valuable research content that is crucial for anyone dedicated to pushing the boundaries of organic chemistry.

CHEMISTRY & BIODIVERSITY is a prominent peer-reviewed journal published by Wiley-V C H Verlag GmbH, serving as a vital resource in the intersecting fields of biochemistry, bioengineering, and miscellaneous chemistry. With an ISSN of 1612-1872 and an E-ISSN of 1612-1880, this journal has established itself over its converged years from 2004 to 2024 as a platform for innovative research that contributes significantly to the understanding of chemical processes in biological systems. The journal's impact is reflected in its category quartiles, particularly notable in Q2 in Chemistry and various Q3 and Q4 rankings across multiple related disciplines. While it is not an open-access publication, it continues to attract a diverse readership, including researchers, academics, and students, who are keen to explore the complexities of chemistry's role in biodiversity. Through high-quality articles and comprehensive reviews, CHEMISTRY & BIODIVERSITY plays an essential role in fostering advances in molecular biology and biochemistry, positioning itself as a key contributor to the ongoing discourse in the life sciences.

MAIN GROUP CHEMISTRY, published by IOS PRESS in the Netherlands, is a dedicated journal that serves as a platform for advanced research in the fields of inorganic, organic, and materials chemistry. With an ISSN of 1024-1221 and an E-ISSN of 1745-1167, this journal caters to a diverse audience, including researchers, professionals, and students aiming to expand their knowledge and understanding of the main group elements and their compounds. Over the years, MAIN GROUP CHEMISTRY has played a pivotal role in showcasing significant findings that push the boundaries of current knowledge, despite being categorized in the Q4 quartile for all three covered fields as of 2023. While not an open access journal, it still provides vital insights and fosters discussions that contribute to the advancement of chemical science. With an evolving publication history since its inception, the journal continues to thrive as a valuable resource in a competitive academic landscape.

BIOORGANIC CHEMISTRY, published by Academic Press Inc., a prestigious imprint of Elsevier Science, represents a cornerstone in the fields of biochemistry, organic chemistry, and drug discovery. With an impressive Scopus rank placing it in the top quartiles across critical categories—including Q2 for Biochemistry and Drug Discovery, and Q1 for Organic Chemistry—this journal has established itself as a vital resource for researchers, professionals, and students alike. Featuring a diverse array of articles that explore innovative methodologies and emerging trends from 1971 to the present, BIOORGANIC CHEMISTRY effectively bridges the gap between laboratory research and practical applications. Although not an Open Access journal, its rigorous peer-review process ensures the delivery of high-quality, impactful research that drives advances in the understanding and application of biochemistry. With an aim to facilitate scientific discourse and collaboration, it invites contributions that further the exploration of chemical processes within biological systems.

Heterocyclic Letters is an esteemed journal in the field of synthetic organic chemistry, published by RAMAN PUBL. With ISSN 2231-3087 and E-ISSN 2230-9632, this journal aims to disseminate original research and innovative findings related to heterocyclic compounds, which play a crucial role in medicinal chemistry, material science, and agricultural chemistry. Heterocyclic Letters provides a platform for researchers, professionals, and students to share their insights and advancements, thus fostering academic collaboration and knowledge transfer. The journal is dedicated to maintaining high-quality standards in research publication, making it an essential resource for anyone focused on the latest developments in heterocyclic chemistry. Although it does not currently offer Open Access options, the journal’s rigorous peer-review process ensures that only the most credible and impactful studies are published, contributing significantly to the advancement of the field.

HETEROCYCLES, published by the Japan Institute of Heterocyclic Chemistry, stands as a pivotal journal within the fields of Analytical Chemistry, Organic Chemistry, and Pharmacology. With its ISSN 0385-5414 and E-ISSN 1881-0942, HETEROCYCLES has been a respected platform for scholarly work since its establishment in 1983, featuring innovative research up until 2022. While currently not open access, the journal is renowned for its rigorous peer-review process, ensuring the dissemination of high-quality research. Despite its Q4 ranking in the 2023 quartiles for its categories, it plays a crucial role in bridging gaps in knowledge and advancing the discourse on heterocyclic compounds, which are vital in drug discovery and development. Researchers, professionals, and students who are engaged in chemistry and pharmacology will find HETEROCYCLES an essential source of cutting-edge studies, insights, and an opportunity to contribute to the evolving landscape of these scientific fields.

Medicinal Chemistry is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of drug discovery and development. Established in 2005 with a converged publication timeframe extending to 2024, this journal serves as a vital resource for researchers and professionals interested in the intricate processes of medicinal chemistry, pharmacology, and toxicology. With an ISSN of 1573-4064 and an E-ISSN of 1875-6638, it has established a notable presence in the academic community, currently positioned in Q3 of Drug Discovery category according to the 2023 quartiles. The journal's ranking in Scopus places it at 90 out of 157 in its field, showcasing its impact and relevance, with a percentile standing of 42. Although the journal is not open access, it continues to provide insightful articles and research findings that contribute significantly to the understanding and innovation in medicinal chemistry. Based in the United Arab Emirates, Medicinal Chemistry is committed to disseminating high-quality research that shapes the future of drug formulation and therapeutic advancement.